TTK Healthcare Limited (NSE:TTKHLTCARE)

Market Cap	11.74B -32.3%
Revenue (ttm)	8.30B +4.7%
Net Income	600.67M -28.3%
EPS	42.51 -28.3%
Shares Out	n/a
PE Ratio	19.54
Forward PE	n/a
Dividend	10.00 (1.20%)
Ex-Dividend Date	Jul 18, 2025

Volume	4,881
Average Volume	5,648
Open	802.05
Previous Close	811.40
Day's Range	802.05 - 839.95
52-Week Range	799.00 - 1,398.90
Beta	-0.02
RSI	28.85
Earnings Date	May 29, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1928
• Employees: 1,339
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TTKHLTCARE

Financial Performance

In fiscal year 2025, TTK Healthcare's revenue was 8.01 billion, an increase of 6.47% compared to the previous year's 7.53 billion. Earnings were 816.57 million, an increase of 29.94%.